BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20152220)

  • 21. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Greenberg BH; Abraham WT; Albert NM; Chiswell K; Clare R; Stough WG; Gheorghiade M; O'Connor CM; Sun JL; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):277.e1-8. PubMed ID: 17643576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
    Dimopoulos K; Salukhe TV; Coats AJ; Mayet J; Piepoli M; Francis DP
    Int J Cardiol; 2004 Feb; 93(2-3):105-11. PubMed ID: 14975535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am J Cardiol; 2009 Jul; 104(1):107-15. PubMed ID: 19576329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY; Frison L; Grind M
    J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart failure patients receiving ACEIs/ARBs were less likely to be hospitalized or to use emergency care in the following year.
    Chen JY; Kang N; Juarez DT; Yermilov I; Braithwaite RS; Hodges KA; Legorreta A; Chung RS
    J Healthc Qual; 2011; 33(4):29-36. PubMed ID: 21733022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
    Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
    Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA; Hussein GM; Hamza EA
    Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care.
    Ahmed A; Allman RM; Kiefe CI; Person SD; Shaneyfelt TM; Sims RV; Howard G; DeLong JF
    Am Heart J; 2003 Jun; 145(6):1086-93. PubMed ID: 12796767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes.
    Masoudi FA; Wolfe P; Havranek EP; Rathore SS; Foody JM; Krumholz HM
    J Am Coll Cardiol; 2005 Sep; 46(6):955-62. PubMed ID: 16168275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial.
    Majumdar SR; Tsuyuki RT; McAlister FA
    Am Heart J; 2007 Jan; 153(1):22.e1-8. PubMed ID: 17174632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
    Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
    Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Valsartan on hospitalization: results from Val-HeFT.
    Carson P; Tognoni G; Cohn JN
    J Card Fail; 2003 Jun; 9(3):164-71. PubMed ID: 12815565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Nunez E; Yancy CW; Young JB
    Circ Heart Fail; 2008 May; 1(1):50-7. PubMed ID: 19808270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.